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Early diagnosis of P. aeruginosa (PA) colonization in patients with cystic ﬁbrosis
(CF) using microbiological culture methods may be difﬁcult. Serology may be a
useful technique for early detection of PA in children with CF.
The purpose of this study was to assess the value of the measurement of antibodies
to PA in diagnosing lung infection by PA in CF patients (pts).
Longitudinal prospective study in which respiratory secretion samples for culture −
expectorated sputum/oropharyngeal swabs − and also sera were collected over
3.6±2.5 years (range 1−8) in 78 CF pts, median age 2.6 y (range 0.5−18).
PA antibody titers were assessed against whole cell protein by enzyme linked
immunoassay. Weighed receiver operating characteristic (ROC) curves were used
to determine best antibody titer cut off values to predict subsequent PA chronic
colonization and PA positive cultures (intermittent or chronic colonization).
Serological test performance was evaluated to diagnose PA colonization. The area
under the curve was 0.865 (95%CI, 0.82–0.91; p< 0.01) and with a cut off
level 4 the sensitivity was 75%, the speciﬁcity 89%, and the positive (PPV) and
negative predictive value (NPV) were 76% and 88% to identify CF pts with chronic
PA colonization respectively. To diagnose intermittent or chronic PA colonization
the area under the curve was 0.76 (95%CI, 0.7−0.8; p< 0.01) and a cut off
level 3 showed a sensitivity of 54% and speciﬁcity 84% with a PPV and NPV
of 49% and 20% respectively.
Conclusion: In CF patients, serological tests using speciﬁc antigens are sensitive
for diagnosing chronic PA colonization. However, this method is less useful to
detect intermittent infection.
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Chronic P. aeruginosa (Pa) infection is considered an unfavorable event for the
prognosis of CF patients. Eradication of Pa at ﬁrst/new isolation could be a
simple and efﬁcacious way to improve prognosis. We analyzed the demographic
characteristics of a large group of patients with ﬁrst/new Pa infections and the
pattern of Pa antibiotic resistance as part of a multicenter randomised controlled
trial analyzing the efﬁcacy of two eradicating treatment protocols (inh colistin/oral
cipro versus inh tobramycin/oral cipro). Patients older than 1 year were considered
eligible to participate in this trial. Thirteen Italian clinical centers participated and
198 patients (94 females, 102 males, 2 missing) were randomized in 24 months.
47.9% patients were treated with colistin inh/oral cipro; 52.1% patients were treated
with tobramycin inh/oral cipro. 11% of patients dropped out. Pa ﬁrst/new infection
happened in patients aged 1−5 years in 36.9%; in patients aged 5−12 years in
37.9% and in patients older than 12 years in 25.2%. 78 patients, free from Pa
infection and eligible for the study, were previously infected by Pa, whereas it was
the ﬁrst infection for the remaining 120 patients. Mean age at ﬁrst Pa infection
was 9.3±7 yrs, median 8, range 1−37. The culture was performed on sputum in
35.3% of patients, on throat swab in 25.6%, on laryngeal suction in 31.7% (missing
data 7.4%). Pa strains showed complete susceptibility to colistin, tobramycin and
ciproﬂoxacin.
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The Liverpool Epidemic Strain of P. aeruginosa (LES) has spread widely among
CF patients in the UK and is associated with increased morbidity. CF centres
are advised to screen and isolate patients with LES to reduce transmission and
therefore a rapid and accurate test for LES is needed. Previous work showed that
PCR assays for PS21 and LES F9 were able to identify most LES. There were
however strains that were positive for only one marker, of which only some were
LES by SNP genomotyping (Clondiag tube array) [1]. To measure the prevalence
of these anomalous strains, we reviewed 2 years of data from the Papworth Adult
CF clinic after PCR screening for LES at each clinic visit was introduced in 2007.
122 patients were tested on average 4−5 times. 33 (27%) were PCR positive for
both LES markers, 16 (13%) had a single gene marker, 9 for F9 and 7 for PS21. 9%
of the patients had different PCR results on different occasions. Of the 16 single
gene positive isolates some were LES by genomotyping, while others were unique
strains.
P. aeruginosa positive for one of the published markers for LES are common in
our patient group. More frequent screening has shown a more complex picture than
previously thought. Single gene positive isolates need conﬁrmatory testing as they
may or may not be LES. Methods to reliably identify LES that can be used routinely
still need to be developed.
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The most predominant transmissible epidemic strain of Pseudomonas aeruginosa
across the UK is the Liverpool Epidemic Strain (LES), which possesses novel
genomic islands and prophages and exhibits a hypervirulent phenotype characterised
by the over-expression of the quorum sensing (QS) regulon (including pyocyanin).
We collected sputum samples from ten adult LES-infected CF patients during
periods of stability and during pulmonary exacerbations. Forty LES isolates from
each sample were subjected to a range of tests to establish various phenotypic and
genotypic characteristics (15 in all). Extensive diversity was found: the ﬁrst 1360
LES isolates could be sub-divided into >350 sub-types (haplotypes). Our analyses
of sequential samples indicated that LES haplotype populations are dynamic
within individual patients. Interestingly, over-production of the toxin pyocyanin was
signiﬁcantly associated (P< 0.05) with samples taken during exacerbations. The
presence or absence of novel LES-speciﬁc genomic islands and prophage regions
varied between individual patients and sample type.
This study indicates that populations of the P. aeruginosa LES are highly variable
and ﬂuctuate in chronically infected CF patients. The diversity and adaptability of
this strain may enhance its ability to transmit and contribute to its overall virulence
within CF patients.
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